From the Journals
HCV testing/awareness successful as part of HIV integrated care
News
From the Journals
Rare mixed HCV genotypes found in men who have sex with men
From the Journals
HCV+ kidney transplants: Similar outcomes to HCV- regardless of recipient serostatus
From the Journals
Direct-acting antiviral therapy boosts survival for infected HCC patients
Adults with a history of hepatocellular carcinoma had a significantly reduced risk of death after treatment of HCV infections with DAAs.
From the Journals
Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality
In sharp contrast with the viral hepatitis findings, mortality rates among patients with ALD and NAFLD have increased.
From the Journals
Spleen/liver stiffness ratio differentiates HCV, ALD
The SS/LS ratio is significantly higher in patients with HCV than in those with alcohol-related liver disease (ALD).
News
Louisiana HCV program cuts costs – and hassles
No prior authorization will be necessary for a specific combination of direct-acting antiviral agents starting July 15.
From the Journals
Despite HCV cure, liver cancer-associated genetic changes persist
Conference Coverage
HCV treatment with DAA regimens linked to reduced diabetes risk
Diabetes incidence was lower in hepatitis C patients treated with DAAs than in untreated patients.
From the Journals
Developing an HCV vaccine faces significant challenges
From the Journals
Possible biomarkers found for progression to liver cancer in chronic HCV infection
Mannose-binding lectin and ficolin-2 are potential biomarkers for the development of liver cancer in chronic HCV infection.
From the Journals
Baby boomers account for more than 74% of chronic HCV cases
From the Journals
DAAs reduce mortality, cancer risk in HCV study
Large, prospective study showed direct-acting antivirals reduced mortality and cancer risk in chronic HCV-infected patients.
From the Journals
Host stress response may be a factor in early-stage HCV clearance